Exploring the Potential of Generative AI in Life Sciences and Drug Development

In a new episode of In the Vault, a16z General Partner David Haber talks with Marty Chavez, a partner and vice chairman of Sixth Street Partners, about the foundational role he’s had in merging technology and finance throughout his career, and the magical promises and regulatory pitfalls of AI.

0-1:30 Intro

1:30-12:50 Marty's history and transition to Wall Street

12:50-20:50 Financial Crisis and SecDB

20:50-32:10 GenAI's impact

32:10-36:15 AI and biotech

36:15-37:06 Outro

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.